Zoetis (ZTS) |
United States |
$85.731B |
34.16 |
Takeda Pharmaceutical (TAK) |
Japan |
$47.124B |
9.43 |
Merck (MKGAF) |
Germany |
$24.039B |
26.23 |
Astellas Pharma (ALPMY) |
Japan |
$22.440B |
26.96 |
Sandoz Group AG (SDZNY) |
Switzerland |
$18.283B |
0.00 |
United Therapeutics (UTHR) |
United States |
$15.377B |
15.88 |
Shionogi (SGIOY) |
Japan |
$13.368B |
12.81 |
Neurocrine Biosciences (NBIX) |
United States |
$12.134B |
36.31 |
Catalent (CTLT) |
United States |
$10.861B |
0.00 |
Summit Therapeutics (SMMT) |
United States |
$8.890B |
0.00 |
Orion OYJ (ORINY) |
Finland |
$7.339B |
29.89 |
Revolution Medicines (RVMD) |
United States |
$6.989B |
0.00 |
Ionis Pharmaceuticals (IONS) |
United States |
$6.856B |
0.00 |
Jazz Pharmaceuticals (JAZZ) |
Ireland |
$6.616B |
7.02 |
Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$5.717B |
0.00 |
Madrigal Pharmaceuticals (MDGL) |
United States |
$5.296B |
0.00 |
Crinetics Pharmaceuticals (CRNX) |
United States |
$4.033B |
0.00 |
Corcept Therapeutics (CORT) |
United States |
$3.592B |
30.42 |
Dyne Therapeutics (DYN) |
United States |
$3.316B |
0.00 |
Arrowhead Pharmaceuticals (ARWR) |
United States |
$2.762B |
0.00 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$2.597B |
14.98 |
PTC Therapeutics (PTCT) |
United States |
$2.426B |
0.00 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$2.326B |
18.49 |
Soleno Therapeutics (SLNO) |
United States |
$1.887B |
0.00 |
Recursion Pharmaceuticals (RXRX) |
United States |
$1.664B |
0.00 |
BioCryst Pharmaceuticals (BCRX) |
United States |
$1.651B |
0.00 |
Centessa Pharmaceuticals (CNTA) |
United Kingdom |
$1.618B |
0.00 |
NewAmsterdam Pharma (NAMS) |
Netherlands |
$1.476B |
0.00 |
Indivior (INDV) |
United States |
$1.427B |
6.55 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$1.395B |
0.00 |
Harrow (HROW) |
United States |
$1.348B |
0.00 |
Ardelyx (ARDX) |
United States |
$1.318B |
0.00 |
Ocular Therapeutix (OCUL) |
United States |
$1.308B |
0.00 |
Cassava Sciences (SAVA) |
United States |
$1.291B |
0.00 |
Calliditas Therapeutics AB (CALT) |
Sweden |
$1.221B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$1.198B |
6.87 |
Evotec AG (EVO) |
Germany |
$1.191B |
0.00 |
ARS Pharmaceuticals (SPRY) |
United States |
$1.101B |
0.00 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.038B |
0.00 |
Enliven Therapeutics (ELVN) |
United States |
$1.013B |
0.00 |
Xencor (XNCR) |
United States |
$0.998B |
0.00 |
Relay Therapeutics (RLAY) |
United States |
$0.835B |
0.00 |
Cronos Group (CRON) |
Canada |
$0.818B |
0.00 |
4D Molecular Therapeutics (FDMT) |
United States |
$0.783B |
0.00 |
Bioventus (BVS) |
United States |
$0.772B |
25.08 |
Savara (SVRA) |
United States |
$0.728B |
0.00 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$0.720B |
45.10 |
USANA Health Sciences (USNA) |
United States |
$0.718B |
13.18 |
ProKidney (PROK) |
United States |
$0.675B |
0.00 |
Pacira BioSciences (PCRX) |
United States |
$0.639B |
6.05 |
Exscientia (EXAI) |
United Kingdom |
$0.622B |
0.00 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.603B |
0.00 |
Silence Therapeutics (SLN) |
United Kingdom |
$0.558B |
0.00 |
Siga Technologies (SIGA) |
United States |
$0.550B |
6.59 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.532B |
0.00 |
Larimar Therapeutics (LRMR) |
United States |
$0.514B |
0.00 |
Eliem Therapeutics (ELYM) |
United States |
$0.496B |
0.00 |
Verve Therapeutics (VERV) |
United States |
$0.473B |
0.00 |
OmniAb (OABI) |
United States |
$0.469B |
0.00 |
Sage Therapeutics (SAGE) |
United States |
$0.458B |
0.00 |
Altimmune (ALT) |
United States |
$0.441B |
0.00 |
Foghorn Therapeutics (FHTX) |
United States |
$0.417B |
0.00 |
Tourmaline Bio (TRML) |
United States |
$0.394B |
0.00 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$0.392B |
0.00 |
Zevra Therapeutics (ZVRA) |
United States |
$0.385B |
0.00 |
Aquestive Therapeutics (AQST) |
United States |
$0.381B |
0.00 |
Korro Bio (KRRO) |
United States |
$0.379B |
0.00 |
Xeris Biopharma Holdings (XERS) |
United States |
$0.374B |
0.00 |
Aldeyra Therapeutics (ALDX) |
United States |
$0.364B |
0.00 |
Lexeo Therapeutics (LXEO) |
United States |
$0.360B |
0.00 |
Elite Pharmaceuticals (ELTP) |
United States |
$0.335B |
31.35 |
Organogenesis (ORGO) |
United States |
$0.327B |
0.00 |
Esperion Therapeutics (ESPR) |
United States |
$0.324B |
0.00 |
Black Diamond Therapeutics (BDTX) |
United States |
$0.305B |
0.00 |
Lyell Immunopharma (LYEL) |
United States |
$0.300B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.284B |
0.00 |
Heron Therapeutics (HRTX) |
United States |
$0.273B |
0.00 |
Prelude Therapeutics (PRLD) |
United States |
$0.267B |
0.00 |
Acrivon Therapeutics (ACRV) |
United States |
$0.250B |
0.00 |
Nanobiotix S.A (NBTX) |
France |
$0.250B |
0.00 |
Enanta Pharmaceuticals (ENTA) |
United States |
$0.245B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.242B |
16.52 |
ESSA Pharma (EPIX) |
Canada |
$0.239B |
0.00 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.234B |
0.00 |
Avita Medical (RCEL) |
United States |
$0.230B |
0.00 |
Nektar Therapeutics (NKTR) |
United States |
$0.206B |
0.00 |
Pyxis Oncology (PYXS) |
United States |
$0.206B |
0.00 |
Profound Medical (PROF) |
Canada |
$0.201B |
0.00 |
Innate Pharma SA (IPHYF) |
France |
$0.184B |
0.00 |
CytoDyn (CYDY) |
United States |
$0.182B |
0.00 |
MediWound (MDWD) |
Israel |
$0.179B |
0.00 |
Context Therapeutics (CNTX) |
United States |
$0.174B |
0.00 |
Amylyx Pharmaceuticals (AMLX) |
United States |
$0.161B |
0.00 |
VAXART, INC (VXRT) |
United States |
$0.157B |
0.00 |
Galectin Therapeutics (GALT) |
United States |
$0.153B |
0.00 |
Telomir Pharmaceuticals (TELO) |
United States |
$0.152B |
0.00 |
Fractyl Health (GUTS) |
United States |
$0.150B |
0.00 |
OptiNose (OPTN) |
United States |
$0.143B |
0.00 |
Achieve Life Sciences (ACHV) |
Canada |
$0.143B |
0.00 |
Cardiol Therapeutics (CRDL) |
Canada |
$0.128B |
0.00 |
Century Therapeutics (IPSC) |
United States |
$0.124B |
0.00 |
Assertio Holdings (ASRT) |
United States |
$0.120B |
21.00 |
Incannex Healthcare (IXHL) |
Australia |
$0.105B |
0.00 |
Metagenomi (MGX) |
United States |
$0.102B |
0.00 |
CASI Pharmaceuticals (CASI) |
China |
$0.101B |
0.00 |
Journey Medical (DERM) |
United States |
$0.097B |
0.00 |
Citius Pharmaceuticals (CTXR) |
United States |
$0.096B |
0.00 |
Regulus Therapeutics (RGLS) |
United States |
$0.096B |
0.00 |
Karyopharm Therapeutics (KPTI) |
United States |
$0.091B |
0.00 |
AlloVir (ALVR) |
United States |
$0.088B |
0.00 |
Aclaris Therapeutics (ACRS) |
United States |
$0.083B |
0.00 |
Verrica Pharmaceuticals (VRCA) |
United States |
$0.082B |
0.00 |
PMV Pharmaceuticals (PMVP) |
United States |
$0.077B |
0.00 |
Marinus Pharmaceuticals (MRNS) |
United States |
$0.077B |
0.00 |
Relmada Therapeutics (RLMD) |
United States |
$0.072B |
0.00 |
Arch Biopartners (ACHFF) |
Canada |
$0.071B |
0.00 |
Vivani Medical (VANI) |
United States |
$0.065B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.058B |
0.00 |
Mural Oncology (MURA) |
Ireland |
$0.054B |
0.00 |
ProPhase Labs (PRPH) |
United States |
$0.052B |
0.00 |
Nutriband (NTRB) |
United States |
$0.049B |
0.00 |
BioLineRx (BLRX) |
Israel |
$0.049B |
0.00 |
DURECT (DRRX) |
United States |
$0.049B |
0.00 |
SCYNEXIS (SCYX) |
United States |
$0.048B |
0.00 |
Reneo Pharmaceuticals (RPHM) |
United States |
$0.048B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.042B |
0.00 |
Carisma Therapeutics (CARM) |
United States |
$0.042B |
0.00 |
Reviva Pharmaceuticals Holdings (RVPH) |
United States |
$0.040B |
0.00 |
FibroGen (FGEN) |
United States |
$0.039B |
0.00 |
ElectroCore (ECOR) |
United States |
$0.038B |
0.00 |
Protara Therapeutics (TARA) |
United States |
$0.038B |
0.00 |
Rafael Holdings (RFL) |
United States |
$0.037B |
0.00 |
Inotiv (NOTV) |
United States |
$0.035B |
0.00 |
Unicycive Therapeutics (UNCY) |
United States |
$0.033B |
0.00 |
Tempest Therapeutics (TPST) |
United States |
$0.031B |
0.00 |
Surrozen (SRZN) |
United States |
$0.030B |
0.00 |
VYNE Therapeutics (VYNE) |
United States |
$0.028B |
0.00 |
Gain Therapeutics (GANX) |
United States |
$0.027B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.027B |
0.00 |
Enlivex Therapeutics (ENLV) |
Israel |
$0.027B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.025B |
0.00 |
MEI Pharma (MEIP) |
United States |
$0.021B |
0.79 |
TherapeuticsMD (TXMD) |
United States |
$0.020B |
0.00 |
Lipocine (LPCN) |
United States |
$0.020B |
0.00 |
Cosmos Health (COSM) |
United States |
$0.019B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.018B |
0.00 |
Minerva Neurosciences (NERV) |
United States |
$0.018B |
0.00 |
Lyra Therapeutics (LYRA) |
United States |
$0.018B |
0.00 |
NRx Pharmaceuticals (NRXP) |
United States |
$0.018B |
0.00 |
Talphera (TLPH) |
United States |
$0.017B |
0.00 |
PolyPid (PYPD) |
Israel |
$0.017B |
0.00 |
Aptorum Group (APM) |
United Kingdom |
$0.016B |
0.00 |
BioVie (BIVI) |
United States |
$0.015B |
0.00 |
XTL Biopharmaceuticals (XTLB) |
Israel |
$0.015B |
0.00 |
Indaptus Therapeutics (INDP) |
United States |
$0.015B |
0.00 |
Mannatech (MTEX) |
United States |
$0.014B |
0.00 |
Nuvilex (PMCB) |
United States |
$0.012B |
0.00 |
Redhill Biopharma (RDHL) |
Israel |
$0.012B |
0.00 |
Conduit Pharmaceuticals (CDT) |
United States |
$0.012B |
0.00 |
Addex Therapeutics (ADXN) |
Switzerland |
$0.012B |
0.00 |
Oncternal Therapeutics (ONCT) |
United States |
$0.012B |
0.00 |
Dominari Holdings (DOMH) |
United States |
$0.011B |
0.00 |
Kiora Pharmaceuticals (KPRX) |
United States |
$0.011B |
0.00 |
Universe Pharmaceuticals INC (UPC) |
China |
$0.011B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.010B |
0.00 |
GlycoMimetics (GLYC) |
United States |
$0.010B |
0.00 |
Inhibikase Therapeutics (IKT) |
United States |
$0.010B |
0.00 |
Viracta Therapeutics (VIRX) |
United States |
$0.010B |
0.00 |
Traws Pharma (TRAW) |
United States |
$0.009B |
0.00 |
Molecular Templates (MTEM) |
United States |
$0.009B |
0.00 |
Vivos Therapeutics (VVOS) |
United States |
$0.009B |
0.00 |
Plus Therapeutics (PSTV) |
United States |
$0.008B |
0.00 |
Mangoceuticals (MGRX) |
United States |
$0.008B |
0.00 |
Avalo Therapeutics (AVTX) |
United States |
$0.008B |
0.00 |
Xenetic Biosciences (XBIO) |
United States |
$0.006B |
0.00 |
Biomerica (BMRA) |
United States |
$0.006B |
0.00 |
CERo Therapeutics Holdings (CERO) |
United States |
$0.005B |
0.00 |
TransCode Therapeutics (RNAZ) |
United States |
$0.005B |
0.00 |
Ainos (AIMD) |
United States |
$0.004B |
0.00 |
Heatwurx (PCSA) |
United States |
$0.004B |
0.00 |
Avenue Therapeutics (ATXI) |
United States |
$0.004B |
0.11 |
XORTX Therapeutics (XRTX) |
Canada |
$0.004B |
0.00 |
SHINECO (SISI) |
China |
$0.004B |
0.00 |
Alaunos Therapeutics (TCRT) |
United States |
$0.004B |
0.00 |
Shuttle Pharmaceuticals Holdings (SHPH) |
United States |
$0.004B |
0.00 |
SciSparc (SPRC) |
Israel |
$0.003B |
0.00 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.003B |
0.00 |
Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.003B |
0.00 |
Quoin Pharmaceuticals (QNRX) |
United States |
$0.003B |
0.00 |
Bio-Path Holdings (BPTH) |
United States |
$0.003B |
0.00 |
60 Degrees Pharmaceuticals (SXTP) |
United States |
$0.002B |
0.00 |
InMed Pharmaceuticals (INM) |
Canada |
$0.002B |
0.00 |
Petros Pharmaceuticals (PTPI) |
United States |
$0.002B |
0.00 |
Phio Pharmaceuticals (PHIO) |
United States |
$0.002B |
0.00 |
Clearmind Medicine (CMND) |
Canada |
$0.002B |
0.00 |
Salarius Pharmaceuticals (SLRX) |
United States |
$0.002B |
0.00 |
Altamira Therapeutics (CYTO) |
Bermuda |
$0.002B |
0.00 |
Qualigen Therapeutics (QLGN) |
United States |
$0.002B |
0.00 |
Aditxt (ADTX) |
United States |
$0.002B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.002B |
0.00 |
PainReform (PRFX) |
Israel |
$0.001B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.000B |
0.00 |
Qilian Holding Group (BGM) |
China |
$0.000B |
0.00 |
Grifols, S.A (GRFS) |
Spain |
$0.000B |
0.00 |
4D Pharma (LBPS) |
United Kingdom |
$0.000B |
0.00 |
NLS Pharmaceutics (NLSP) |
Switzerland |
$0.000B |
0.00 |
Procaps Group, S.A (PROC) |
Luxembourg |
$0.000B |
3.73 |
Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |
RVL Pharmaceuticals (RVLP) |
United States |
$0.000B |
0.00 |
Stevanato Group S.p.A (STVN) |
Italy |
$0.000B |
39.57 |